A multicentre, open, prospective, randomized study analyzing Hiv-1 Rna Decay in Semen and Rectum with Dtg plus 3Tc Versus Bic/ Ftc/Taf
Latest Information Update: 25 Mar 2022
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Dolutegravir/lamivudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
Most Recent Events
- 25 Mar 2022 New trial record
- 16 Feb 2022 Results presented at the 29th Conference on Retroviruses and Opportunistic Infections